Keywords: alogliptin, delayed, due, lack, fda, resources, food

Alogliptin delayed due to lack of FDA resources

Article | 20 October 2008

Print This

The US Food and Drug Administration says the review of the New Drug Application of Takeda's type 2 diabetes drug alogliptin ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in